GlaxoSmithKline plc (NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the publication in the New England ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA Management Comments

Landmark IMPACT Study Published in NEJM Shows Significant Benefits of Trelegy Ellipta for Patients with COPDApril 18, 2018 5:00 PM